VistaGen Therapeutics
VTGN
VTGN
25 hedge funds and large institutions have $1.76M invested in VistaGen Therapeutics in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55.7K | |
| 2 | +$51K | |
| 3 | +$22K | |
| 4 |
Koshinski Asset Management
Decatur,
Illinois
|
+$14K |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$7K |
Top Sellers
| 1 | -$947K | |
| 2 | -$31.5K | |
| 3 | -$25.5K | |
| 4 |
CWA
Clarus Wealth Advisors
Peoria,
Arizona
|
-$16K |
| 5 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
-$8.26K |